openPR Logo
Press release

Investigation announced for Long-Term Investors in shares of Syneos Health, Inc. (NASDAQ: SYNH)

08-15-2019 12:37 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in Syneos Health, Inc. (NASDAQ: SYNH) shares.

An investigation on behalf of current long term investors in Syneos Health, Inc. (NASDAQ: SYNH) shares.

An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Syneos Health, Inc..

Investors who are current long term investors in Syneos Health, Inc. (NASDAQ: SYNH) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: SYNH stocks follows a lawsuit filed against Syneos Health, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: SYNH stocks, concerns whether certain Syneos Health, Inc. directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the District of New Jersey the plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that Syneos Health’s internal control over financial reporting was inadequate, that concerns regarding Syneos Health’s internal control over financial reporting would result in heightened regulatory scrutiny and an SEC investigation into the company’s revenue accounting policies, internal controls and related matters, and that as a result, defendants’ statements about Syneos Health’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.

Those who purchased shares of Syneos Health, Inc. (NASDAQ: SYNH) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Syneos Health, Inc. (NASDAQ: SYNH) here

News-ID: 1822417 • Views:

More Releases from Shareholders Foundation

Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: JHX) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements. Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT)
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced. Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherapeutics (NASDAQ: MLTX)
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements. Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc. Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for Syneos

Nursing Staffing Solutions Market 2023 Business Tactics | TeamHealth, Syneos Hea …
This comprehensive Report of the Nursing Staffing Solutions Market provides real information about the statistics and state of the global and regional market. Its scope study extends from the market situation to comparative pricing between the main players, spending in specific market areas, and profits. It represents a comprehensive and succinct analysis report of the main competitor and price statistics with a view to helping beginners establish their place and
Oncology Clinical Trials Market Next Big Thing | Major Giants- IQVIA, PAREXEL, S …
Advance Market Analytics published a new research publication on "Oncology Clinical Trials Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Oncology Clinical Trials market was mainly driven by the increasing R&D spending across the world. Major Players Profiled in the
Bioanalytical Services Market To Witness Excellent Growth | IQVIA, Syneos Health …
HTF Market Intelligence published a new research document of 150+pages on" Bioanalytical Services Market Insights, to 2028" with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Bioanalytical Services market was mainly driven by the increasing R&D spending by leading and emerging player, however latest scenario and economic slowdown have
Clinical CRO Market Trends and Growth During 2021-2027 | IQVIA, Covance, Syneos …
A contract research organization (CRO) is a company that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. The Growing demand for clinical trials in emerging countries along with increasing prevalence of chronic diseases is accelerating the market growth. Additionally, the market is driven by an increasing number of biologics and the demand for CROs to conduct clinical trials.
Cervical Dystonia Pipeline 2020-2022| Revance Therapeutics, Inc., Syneos Health, …
The Global Cervical Dystonia Pipeline Insights 2020-2022: The research study has been prepared with the use of in-depth qualitative and quantitative analyses of the global Cervical Dystonia Market. The report offers complete and intelligent analysis of the competition, segmentation, dynamics, and geographical advancement of the Global Cervical Dystonia Market. It takes into account the CAGR, value, volume, revenue, production, consumption, sales, Manufacturing cost, prices, and other key factors related to the
Bioanalytical Services Market SWOT Analysis by Key Players- ICON, Algorithme, PR …
A new business intelligence report released by HTF MI with title "Global Bioanalytical Services Market Size, Status and Forecast 2019-2025" is designed covering micro level of analysis by manufacturers and key business segments. The Global Bioanalytical Services Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both qualitative and